Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ciacci

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Journal of Nephrology|June 1, 2006
Sevelamer worsens metabolic acidosis in hemodialysis patientsN G De Santo, A Frangiosa, P Anastasio, et al.
The American Journal of Gastroenterology|August 17, 2004
Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter studyM G Clemente, M P Musu, R Troncone, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 6, 2022
Efficacy of ustekinumab in the treatment of patients with Crohn's disease with failure to previous conventional or biologic therapy: a prospective observational real-life studyA Miranda, A G Gravina, A Cuomo, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Journal of Nephrology|June 1, 2006
Sevelamer worsens metabolic acidosis in hemodialysis patientsN G De Santo, A Frangiosa, P Anastasio, et al.
The American Journal of Gastroenterology|August 17, 2004
Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter studyM G Clemente, M P Musu, R Troncone, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|January 6, 2022
Efficacy of ustekinumab in the treatment of patients with Crohn's disease with failure to previous conventional or biologic therapy: a prospective observational real-life studyA Miranda, A G Gravina, A Cuomo, et al.
Pageof 11